Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Major Shareholding Notification 2020

May 13, 2020

62142_rns_2020-05-13_7efacdc3-6705-41b7-9079-41c6b72b2f5b.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai — 400001. Bandra (E), Mumbai — 400051. Scrip Code: 524404 Symbol: MARKSANS

BSE Limited National Stock Exchange of India Limited

13 May, 2020

Sub: Disclosure under Regulation 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Dear Sirs,

Forwarding herewith disclosures made by Mr. Mark Saldanha and Mrs. Sandra Saldanha, promoters of Marksans Pharma Limited, under the provisions of Regulations 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

Please note that due to lockdown on account of Covid 19 Pandemic, the above promoters are not in a position to provide a signed disclosure. However, we have received the above disclosure through mail from the promoters based on which this disclosure is being made through the Exchanges' disclosure portal in addition to the e-mail sent today.

Thanking you.

Yours faithfully, For Marksans Pharma Limited

Harshavardhan Panigrahi Company Secretary & Compliance Officer

Enclosed as above

CIN : L24110MH1992PLC066364 www.marksanspharma.com

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 © Tel.: +91 22 4001 2000 ¢ Fax : +91-22 4001 2011 E-mail: info@ marksanspharma.com

2" April, 2020

Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai — 400001. Bandra (E), Mumbai — 400051. Scrip Code: 524404 Symbol: MARKSANS

BSE Limited National Stock Exchange of India Limited

Sub: Disclosure under Regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Dear Sir,

We, the undersigned as promoters of Marksans Pharma Limited, hereby enclose disclosure of our shareholding in Marksans Pharma Limited as on 31°' March, 2020 pursuant to the Regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Thanking you.

Yours faithfully,

Sd/- Sd/- Mark Saldanha Sandra Saldanha

Enclosed as above

CC.: Marksans Pharma Limited 11" Floor, Grandeur, Off Veera Desai Extension Road, Oshiwara, Andheri (West), Mumbai — 400053.

Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Part A: Details of Shareholding

under
Regulation
Disclosures
and
30(1)
30(2)
of
(Substantial
SEBI
Acquisition Shares
&
of
Takeovers) Regulations, 2011
Part A: Details of Shareholding
Name of the Target Company (TC)
1.
MARKSANS PHARMA LIMITED
Name(s) of the Stock Exchange(s) where the
2.
shares of the TC are listed
1. The National Stock Exchange Limited
2. BSE Limited
Particulars of the shareholder
3.
Name of person whose total holding (including
a.
that in the form of shares, warrants, convertible
securities and any other instrument that would
entitle the holder to receive shares in the target
company)
more than
25%
share
of the
or
is
Not Applicable
voting rights of the TC.
or
member
Name(s)
promoter(s),
the
of
of
b.
promoter group and Persons Acting in Concert
(PAC) with him.
1.Mr. Mark Saldanha
2.Mrs. Sandra Saldanha
Particulars of the holding of persons mentioned at
4.
(3) above
Number % w.r.t. total
share /voting
capital
wherever
applicable
of _
%
total
diluted
share/voting
capital of TC (*)
As on March 31* of the year 2020, holding of:
a) Shares
Mr. Mark Saldanha
1.
197491553 48.25 48.24
Mrs. Sandra Saldanha
2.
180 0.00 0.00
b) Voting Right (otherwise than by shares) - - -
c) Warrants
d) Convertible Securities
- - -
e) Any other instruments that would entitle the -
-
-
-
-
-
holder to receive shares in the TC
TOTAL 197491733 48.25 48.24

(*)Diluted shares/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. It includes 81314 equity shares that might be issued in case conversion right is exercised by all the holders of outstanding Foreign Currency Convertible Bonds of the TC.

Sd/- Sd/- Mark Saldanha Sandra Saldanha

Place: Mumbai Date: 2" April, 2020

Part B

Name of the Target Company (TC): Marksans Pharma Limited

Part B
Name of the Target Company (TC): Marksans Pharma Limited
Names of the person and
Persons Acting Concert(PAC)
Whether the
person
belong to
promoter or promoter group
PAN of the person and PAC
with the person
Mr. Mark Saldanha
Yes

Sd/- Sd/- Mark Saldanha Sandra Saldanha

Place: Mumbai Date: 2"? April, 2020 Corporate Relation Department Listing Department Phiroze Jeejeeboi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai — 400001. Bandra (E), Mumbai — 400051. Scrip Code: 524404 Symbol: MARKSANS

BSE Limited National Stock Exchange of India Limited

Sub: Disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011

Dear Sir,

We, the undersigned as promoters of Marksans Pharma Limited, hereby declare under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 that we have not made any encumbrance , directly or indirectly, of our shares held in Marksans Pharma Limited.

Thanking you.

Yours faithfully,

Sd/- Sd/- Mark Saldanha Sandra Saldanha

CC.: Audit Committee of Directors Marksans Pharma Limited 11" Floor, Grandeur, Off Veera Desai Extension Road, Oshiwara, Andheri (West), Mumbai — 400053.